[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Goodrx Holdings Inc Cl A (GDRX)

Goodrx Holdings Inc Cl A (GDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 907,821
  • Shares Outstanding, K 342,574
  • Annual Sales, $ 796,850 K
  • Annual Income, $ 30,440 K
  • EBIT $ 164 M
  • EBITDA $ 251 M
  • 60-Month Beta 1.54
  • Price/Sales 1.10
  • Price/Cash Flow 6.40
  • Price/Book 1.41

Options Overview Details

View History
  • Implied Volatility 67.43% (+10.72%)
  • Historical Volatility 55.31%
  • IV Percentile 5%
  • IV Rank 14.13%
  • IV High 174.19% on 12/29/25
  • IV Low 49.85% on 05/18/26
  • Expected Move (DTE 23) 0.30 (11.23%)
  • Put/Call Vol Ratio 0.06
  • Today's Volume 851
  • Volume Avg (30-Day) 1,445
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 33,311
  • Open Int (30-Day) 33,584
  • Expected Range 2.35 to 2.95

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.04
  • Number of Estimates 4
  • High Estimate $0.05
  • Low Estimate $0.03
  • Prior Year $0.05
  • Growth Rate Est. (year over year) -20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.23 +18.57%
on 04/23/26
3.00 -11.67%
on 05/11/26
+0.28 (+11.81%)
since 04/22/26
3-Month
1.77 +49.72%
on 03/02/26
3.00 -11.67%
on 05/11/26
+0.18 (+7.29%)
since 02/20/26
52-Week
1.77 +49.72%
on 03/02/26
5.81 -54.39%
on 10/09/25
-1.17 (-30.63%)
since 05/22/25

Most Recent Stories

More News
3 Value Stocks That Fall Short

3 Value Stocks That Fall Short

GDRX : 2.65 (+3.52%)
PSKY : 10.46 (+1.75%)
EPC : 17.66 (+1.61%)
GoodRx, RadNet, Addus HomeCare, Novavax, and Mettler-Toledo Shares Plummet, What You Need To Know

GoodRx, RadNet, Addus HomeCare, Novavax, and Mettler-Toledo Shares Plummet, What You Need To Know

GDRX : 2.65 (+3.52%)
NVAX : 9.21 (+2.56%)
MTD : 1,103.09 (+1.16%)
RDNT : 54.40 (-0.07%)
ADUS : 92.65 (-0.65%)
The 5 Most Interesting Analyst Questions From GoodRx’s Q1 Earnings Call

The 5 Most Interesting Analyst Questions From GoodRx’s Q1 Earnings Call

GDRX : 2.65 (+3.52%)
1 Mooning Stock on Our Buy List and 2 We Question

1 Mooning Stock on Our Buy List and 2 We Question

GDRX : 2.65 (+3.52%)
DDOG : 222.32 (+1.96%)
LGIH : 46.11 (-0.26%)
GoodRx Q1 Earnings Call Highlights

GoodRx (NASDAQ:GDRX) reported first-quarter 2026 results that management said showed “continued momentum across our strategic growth priorities,” driven by growth in its Pharma Direct business and...

GDRX : 2.65 (+3.52%)
GoodRx (GDRX) Stock Trades Up, Here Is Why

GoodRx (GDRX) Stock Trades Up, Here Is Why

GDRX : 2.65 (+3.52%)
GoodRx (NASDAQ:GDRX) Beats Q1 CY2026 Sales Expectations

GoodRx (NASDAQ:GDRX) Beats Q1 CY2026 Sales Expectations

GDRX : 2.65 (+3.52%)
GoodRx Reports First Quarter 2026 Results

Pharma Direct Revenue Increased 82% Year-Over-Year in the First Quarter Company Raises Full Year 2026 Revenue and Adjusted EBITDA Expectations

GDRX : 2.65 (+3.52%)
GoodRx's Prescription Volume Problem: Just Rite Aid Fallout or Something More Structural

Barchart Research What to Expect from GDRX Earnings GDRX Generated May 5, 2026 Current Price $2.56 EPS Estimate $$0.03 Consensus Rating Hold Average Move 7.99% GoodRx's Prescription Volume Problem: Just...

GDRX : 2.65 (+3.52%)
GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect

GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect

GDRX : 2.65 (+3.52%)

Business Summary

GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California.

See More

Key Turning Points

3rd Resistance Point 2.81
2nd Resistance Point 2.74
1st Resistance Point 2.69
Last Price 2.65
1st Support Level 2.58
2nd Support Level 2.51
3rd Support Level 2.46

See More

52-Week High 5.81
Fibonacci 61.8% 4.27
Fibonacci 50% 3.79
Fibonacci 38.2% 3.31
Last Price 2.65
52-Week Low 1.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.